Join Lab-Aids at the NJSC conference this October in Princeton, NJ.
Make sure to mark your calendars to attend our workshops and stop by our booth to talk us.
WORKSHOPS:
Tuesday, October 18th
3E Evolution: The Full Course: Modeling Antibiotic Resistance | 8:30-9:30a | Witherspoon
From Middle School Issues and Science, Redesigned for the NGSS
Students use a model to explore the cause-and-effect relationship between inappropriate use of antibiotics and the phenomenon of the evolution of antibiotic resistance. As they use the model, students use mathematical representations to support their analysis of patterns and trends in the results and to develop explanations for how and why the population of bacteria is changing.
Not Your Usual Elementary STEM Workshop: Make a Ride For One of Your Toys | 12-1p | DOD
From Tinkering Labs, Presented by Lab-Aids for K-5
This hands-on workshop challenges participants to make a vehicle to move a toy or other small object using motors, wheels, wires, and other equipment. This activity is one of 10 engineering design challenges in the Electric Motors Catalyst, a STEM curriculum for grades K-5 that comes complete with equipment, lesson plans, assessments, embedded support for ELA, and is NGSS focused. The program is distributed by Lab-Aids. Lesson samples and literature will be distributed.
Wednesday, October 19th
Exploring the Evolutionary Connection Between Cystic Fibrosis and Tuberculosis | 11a-12p | Wilson
Use a computer simulation to analyze and interpret mathematical data that explores the evolutionary connection between cystic fibrosis (a genetic disease) and tuberculosis (an infectious disease) and evaluate mathematical representation. Takeaways: 1. Learn about the cause-and-effect relationship between being a CF carrier and experiencing less severe TB symptoms; 2. Explore the mathematical effects of changing environmental variables (prevalence of TB and access to high quality health care) on the frequency of the CF mutation; and 3. Make predictions about the future frequency of the CF mutation based on advances in treatment of CF.